Publicatie

Publication date

Health literacy, information provision and satisfaction in advanced cancer consultations: two observational studies using level of education as a proxy.

Vliet, L.M. van, Noordman, J., Mijnlieff, M., Roodbeen, R., Boland, G., Dulmen, S. van. Health literacy, information provision and satisfaction in advanced cancer consultations: two observational studies using level of education as a proxy. BMJ Supportive & Palliative Care: 2021
Download the PDF
Objectives
Patients with low health literacy (LHL) might feel less informed and satisfied with provided information than patients with high health literacy (HHL). In the setting of advanced cancer, we explored whether LHL patients, compared with HHL patients are: (1) often less informed, and (2) less satisfied with clinicians’ communication (a) in general and (b) following information provision specifically.

Methods
Data from two observational studies using recorded consultations were combined. Clinicians’ provided information and patients’ health literacy level—defined by educational levels—and satisfaction were measured. Χ2 tests and regression (moderation) analyses assessed the relation between health literacy and information provision, and between information provision and satisfaction, meanwhile exploring moderating influences of health literacy.

Results
Of 61 included patients, 25 (41%) had LHL. LHL and HHL patients were equally seldom informed about the disease’s incurability (36% vs 42%, p=0.66). LHL patients were more often informed about the option of not pursuing anticancer therapy than HHL patients (28% vs 8%, p=0.04). LHL patients were more satisfied with clinicians’ communication than HHL patients (M=9.3 vs M=8.5, p=0.03), especially when the option of no anticancer treatment was discussed (p=0.04). Discussing the disease’s incurability did not influence satisfaction levels (p=0.58) for LHL and HHL patients.

Conclusions
LHL patients were not less informed, yet more satisfied than HHL patients. Both groups were equally seldom informed about the disease’s incurability. No anticancer therapy was mostly discussed with LHL patients who were more satisfied following this information. Clinicians should be encouraged to inform all patients about the disease status and (non)treatment options, while not overlooking empathic support.